Unmarried status is a barrier for access to treatment in patients with metastatic renal cell carcinoma
We tested the effect of marital status on cytoreductive nephrectomy, metastasectomy, and systemic therapy rates, as well as on cancer-specific mortality (CSM) in patients with metastatic clear cell renal carcinoma (mccRCC).
Within the Surveillance, Epidemiology and End Results database (2004–2015), we identified 6975 patients (4806 men and 2169 women) with metastatic clear cell renal carcinoma. Temporal trend analyses, logistic regression models, cumulative incidence plots, and competing-risk regression models were used.
Overall, 1450 men and 1018 women were unmarried (30.2% and 47.0%, respectively). In men, unmarried status was an independent predictor of lower cytoreductive nephrectomy rate (OR: 0.54), lower metastasectomy rate (OR: 0.70), and lower systemic therapy rate (OR: 0.70). Conversely, in women, unmarried status was an independent predictor of lower cytoreductive nephrectomy rate (OR: 0.63) and of lower systemic therapy rate (OR: 0.80), but not of lower metastasectomy rate (OR: 0.83; p = 0.12). In multivariable competing-risk regression analyses, unmarried status was an independent predictor of higher CSM in men (HR: 1.15), but not in women (HR 0.97, p = 0.6).
Unmarried men are at higher risk of not benefiting of cytoreductive nephrectomy, metastasectomy, or systemic therapy than their married counterparts. Unmarried women are at higher risk of not benefiting of cytoreductive nephrectomy or systemic therapy. These gender-related differences cumulate in higher CSM in unmarried men, but not in unmarried women.
KeywordsClear cell Kidney cancer Marital status Metastatic SEER database Survival
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Compliance with ethical standards
Conflict of interest
All authors declare no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
- 1.Abdollah F, Sun M, Thuret R, Abdo A, Morgan M, Jeldres C et al (2011) The effect of marital status on stage and survival of prostate cancer patients treated with radical prostatectomy: a population-based study. Cancer Causes Control 22:1085–1095. https://doi.org/10.1007/s10552-011-9784-x CrossRefPubMedGoogle Scholar
- 2.Sammon JD, Morgan M, Djahangirian O, Trinh Q-D, Sun M, Ghani KR et al (2012) Marital status: a gender-independent risk factor for poorer survival after radical cystectomy: marital status and survival after radical cystectomy. BJU Int 110:1301–1309. https://doi.org/10.1111/j.1464-410X.2012.10993.x CrossRefPubMedGoogle Scholar
- 9.Marchioni M, Martel T, Bandini M, Pompe RS, Tian Z, Kapoor A et al (2017) Marital status and gender affect stage, tumor grade, treatment type and cancer specific mortality in T1–2 N0 M0 renal cell carcinoma. World J Urol 35:1899–1905. https://doi.org/10.1007/s00345-017-2082-9 CrossRefPubMedGoogle Scholar
- 12.Rampersaud EN, Klatte T, Bass G, Patard J-J, Bensaleh K, Böhm M et al (2014) The effect of gender and age on kidney cancer survival: younger age is an independent prognostic factor in women with renal cell carcinoma. Urol Oncol 32(30):e9–e13. https://doi.org/10.1016/j.urolonc.2012.10.012 CrossRefGoogle Scholar
- 20.Xiao W-J, Zhu Y, Dai B, Zhang H-L, Ye D-W (2015) Assessment of survival of patients with metastatic clear cell renal cell carcinoma after radical cytoreductive nephrectomy versus no surgery: a SEER analysis. Int Braz J Urol 41:288–295. https://doi.org/10.1590/S1677-5538.IBJU.2015.02.15 CrossRefPubMedPubMedCentralGoogle Scholar
- 23.Palumbo C, Pecoraro A, Knipper S, Rosiello G, Tian Z, Shariat SF et al (2019) Survival and complication rates of metastasectomy in patients with metastatic renal cell carcinoma treated exclusively with targeted therapy: a combined population-based analysis. Anticancer Res 39:4357–4361. https://doi.org/10.21873/anticanres.13604 CrossRefPubMedGoogle Scholar
- 24.Hanna N, Sun M, Meyer CP, Nguyen PL, Pal SK, Chang SL et al (2016) Survival analyses of patients with metastatic renal cancer treated with targeted therapy with or without cytoreductive nephrectomy: a national cancer data base study. J Clin Oncol 34:3267–3275. https://doi.org/10.1200/JCO.2016.66.7931 CrossRefPubMedPubMedCentralGoogle Scholar